The verdict is Johnson & Johnson's eighth trial victory in talc cases this year, its fourth win since October and its second triumph last week. The scorecard is a reversal of earlier cases where the company was getting battered. In other health industry and insurance news: J&J acquires remaining stake in Verb Surgical; Cigna partners with Prime Therapeutics; Mayo Clinic taps IT vet for digital business; and more.
from Kaiser Health News https://ift.tt/395gW0T
December 23, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
With Polio’s Return, Here’s What Back-to-Schoolers Need to KnowBefore polio vaccines became available in the 1950s, people wary of the disabling disease were afraid to allow their children outside, let alone go to school. As polio appears again decades after it was considered eliminated … Read More
Texas, Battling Teen Pregnancy, Recasts Sex Education StandardsDALLAS — J.R. Chester got pregnant the summer before her senior year of high school. A bright student with good grades, she gave birth, graduated, and was pregnant again when she arrived at college that fall. She was a teen m… Read More
Centene to Pay $166 Million to Texas in Medicaid Drug Pricing SettlementHealth insurance giant Centene Corp. has agreed to pay $165.6 million to Texas to resolve claims that it overcharged the state’s Medicaid program for pharmacy services. It’s the biggest known payout by the nation’s largest Me… Read More
Journalists Look Into Wildfire Trauma and the South’s Monkeypox ResponseKHN reporter and producer Heidi de Marco discussed the impact of wildfire trauma on children in Northern California on CapRadio’s “Insight With Vicki Gonzalez” on Sept. 13. Click here to hear de Marco on CapRadio Read de Mar… Read More
Private Equity Sees the Billions in Eye Care as Firms Target High-Profit ProceduresST. LOUIS — Christina Green hoped cataract surgery would clear up her cloudy vision, which had worsened after she took a drug to fight her breast cancer. But the former English professor said her 2019 surgery with Ophthalmolo… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment